People · Operator
Named in public records as an officer, director or promoter · active 2009–2011 · Other Health Care, Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neomend Inc | — | Other Health Care | Series B | $48.9M | $221.5M | 2009 |
| Zelos Therapeutics Inc | — | Pharmaceuticals | Series A | $17.8M | $75.0M | 2009 |
| Transave Inc | — | Biotechnology | Series A | $13.0M | $72.3M | 2009 |
Alex Barkas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alex Barkas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Nielsen | 1 | 13 |
| Albert Cha | 1 | 9 |
| Richard S. Kollender | 1 | 7 |
| Jack B. Nielsen | 1 | 6 |
| Joseph Zakrzewski | 1 | 6 |
| Farah Champsi | 1 | 5 |
| Colin Goddard | 1 | 5 |
| Brian MacDonald | 1 | 4 |
| Jaisim Shah | 1 | 3 |
| David Krause | 1 | 3 |
| Jeff Courtney | 1 | 3 |
| Donald Hayden | 1 | 3 |
| Abhi Acharya | 1 | 3 |
| Donald Hayden, Jr. | 1 | 3 |
| Timothy Mills | 1 | 3 |
| Jeffrey Courtney | 1 | 2 |
| Alan Roemer | 1 | 2 |
| David Renzi | 1 | 2 |
| DAVID M. RENZI | 1 | 2 |
| Cynthia Lavoie | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.